The PAN Foundation Opens Atopic Dermatitis Patient Assistance Fund
April 26th 2019The PAN Foundation today opened a new patient assistance program for people living with atopic dermatitis. Atopic dermatitis, also known as eczema, is an itchy inflammation of the skin. It is a chronic disease that affects the integumentary system.
Read More
The PAN Foundation Joins the Medicare Access for Patients Rx Coalition
April 26th 2019The Patient Access Network (PAN) Foundation has joined MAPRx (Medicare Access for Patients Rx), a coalition of patient, family caregiver, and health professional organizations committed to safeguarding the well-being of patients with chronic diseases and disabilities who rely on Medicare Part D, Medicare’s prescription drug coverage.
Read More
The PAN Foundation Opens New Carcinoid Syndrome Patient Assistance Fund
April 17th 2019The Patient Access Network (PAN) Foundation today opened a new patient assistance program for people living with carcinoid syndrome. Carcinoid syndrome occurs when an underlying carcinoid tumor produces excessive amounts of serotonin, often due to liver metastases.
Read More
The PAN Foundation Opens New Waldenstrom Macroglobulinemia Patient Assistance Fund
April 2nd 2019The Patient Access Network (PAN) Foundation today opened a new patient assistance program for people living with Waldenstrom macroglobulinemia, a rare type of blood cancer that originates in the lymphatic system and is characterized by an excess of abnormal white blood cells and proteins called immunoglobulins.
Read More
Dr Mark Fendrick, PAN Foundation's Dan Klein Commend Trump Administration's Drug Rebate Proposal
February 26th 2019In a commentary, Dan Klein, president and chief operating officer of the Patient Access Network Foundation, and A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design at the University of Michigan, called the Trump administration's recent drug rebate proposal an opportunity to significantly lower out-of-pocket precription drug costs for Medicare patients.
Read More